替加环素相关凝血功能障碍一例
本文报告一例63岁病态肥胖男性因疑似感染性褥疮接受替加环素治疗后出现凝血功能障碍,INR从1.2升至2.1,经新鲜冰冻血浆治疗成功,停用替加环素并换用其他抗菌药后INR数日内恢复正常。提示替加环素可能引起凝血功能障碍,临床应监测INR。
要点
- 替加环素治疗期间应监测INR,警惕凝血功能障碍。
- 本例INR从1.2升至2.1,停用替加环素后数日内恢复正常。
- 凝血功能障碍经新鲜冰冻血浆治疗成功,未影响手术。
核心结论
- 替加环素可能与凝血功能障碍相关,停用后INR可恢复正常。
研究设计与样本
- 个案报告:一例63岁病态肥胖男性患者。
主要发现
- 替加环素启用后数日内INR为1.2,约三周后术前检查发现INR升至2.1。
- 未发现INR升高的其他明确原因,凝血功能障碍经新鲜冰冻血浆治疗成功。
- 停用替加环素并换用其他抗菌药后,INR数日内恢复正常。
临床怎么用
- 使用替加环素期间应监测INR,尤其出现不明原因升高时。
- 疑似替加环素相关凝血功能障碍时,应考虑停药并换用替代抗菌药。
局限性
- 仅为单个病例报告,无法确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A case of coagulopathy in association with tigecycline use is described. SUMMARY: A 63-year-old morbidly obese, wheelchair-bound man was hospitalized for assessment of a possibly infected decubitus ulcer and surgical evaluation for placement of a diverting colostomy; he had been transferred from another facility after initiation of triple-agent antimicrobial therapy for suspected fecal infection of the ulcer. Based on the results of an ulcer swab culture, the patient's antibiotic regimen was modified (initially to i.v. ertapenem and then to tigecycline on hospital day 10). An International Normalized Ratio (INR) value obtained incidentally within days of tigecycline initiation was slightly elevated (1.2), but no workup was performed at that time. It was determined that the patient would benefit from a colostomy procedure, which was performed about three weeks later (he spent most of the intervening time at a rehabilitation facility, where i.v. tigecycline therapy was continued). During a routine preoperative workup, the patient's INR was found to be elevated (2.1). No identifiable causes for the INR elevation were noted, and the coagulopathy was treated successfully with fresh frozen plasma; the colostomy procedure was uncomplicated. Postoperatively, it was theorized that the development of coagulopathy in this case might have been secondary to tigecycline use. After discontinuation of tigecycline therapy and a switch to an alternative antimicrobial regimen, the patient's INR values normalized within a few days. CONCLUSION: A patient with a possibly infected decubitus ulcer was treated with tigecycline and subsequently developed a coagulopathy.
引用
- McMahan J, Moenster RP. Tigecycline-induced coagulopathy. Am J Health Syst Pharm. 2017. PMID: 28122754. doi:10.2146/ajhp150894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。